Highland Therapeutics Inc

Medicus Pharma Ltd is a Toronto-based biotech life sciences company dedicated to accelerating the clinical development of novel and disruptive therapeutic assets. With a leadership team boasting decades of cumulative experience, the company focuses on progressing innovative pharmaceuticals, biologics, and combination devices through clinical evaluation and regulatory approval. Driven by patience, persistence, and perseverance, Medicus Pharma aims to advance novel therapies, including a non-invasive regimen for treating skin cancer. The company's commitment to innovation positions it as a significant player in the pharmaceutical industry. Generated from the website

Quantum Biopharma Ltd is a research and development company based in Toronto, ON, specializing in the field of biopharmaceuticals. The company focuses on innovative drug discovery and development to address unmet medical needs. Utilizing cutting-edge technology and scientific expertise, Quantum Biopharma Ltd is committed to advancing healthcare through the creation of novel pharmaceutical solutions. The company's mission is to improve patient outcomes and contribute to the advancement of medical science. Generated from their business information

Thiogenesis Therapeutics Corp is a clinical-stage biotech company based in Toronto, specializing in the development of novel thiol compounds that exhibit strong antioxidant and anti-inflammatory properties. Their lead compound, TTI0102, aims to address inherited and acquired mitochondrial diseases, including metabolic disorders such as type 2 diabetes and cardiovascular disease, by enhancing intracellular cysteine levels and promoting glutathione synthesis. The company is focused on pediatric diseases characterized by oxidative stress and currently has plans to initiate three human efficacy trials in collaboration with leading research institutions. Thiogenesis Therapeutics has engineered its proprietary compounds to overcome historical challenges associated with thiol-based drugs, including short half-life and gastrointestinal side effects, demonstrating promising tolerability in early human studies. Generated from the website